Answers are grounded in this paper and cite their sources.
Biologics have made groundbreaking treatments possible, for several difficult to treat conditions. However, they are very expensive, and biosimilars are expected to push prices down like the generics of small molecule drugs did in the past, replacing more costly brandname drugs.
No takes yet. Share an insight, caveat, or question.
Pillai et al. (2017) studied this question.